Chronic Fatigue Syndrome: A Complex Multisystem Disorder
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affects millions worldwide with debilitating fatigue, post-exertional malaise, and cognitive impairment. Environmental chemical exposures may trigger or perpetuate the condition.
Mitochondrial Dysfunction and PFAS
PFAS inhibit electron transport chain complexes, impairing ATP production. Cellular energy deficiency—a hallmark of ME/CFS—may be exacerbated by PFAS-induced mitochondrial dysfunction, explaining some cases of persistent fatigue.
Immune Activation Patterns
ME/CFS patients show activated Natural Killer cell dysfunction and elevated inflammatory cytokines. PFAS produce similar immune activation patterns, potentially lowering the threshold for ME/CFS development after viral or other triggers.
Environmental Medicine Approach
ME/CFS specialists should include PFAS toxicant assessment in comprehensive evaluations. Mitochondrial-supportive supplements and PFAS exposure reduction may offer modest symptomatic benefits for some patients.